FibroGen Inc (FGEN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

409 ILLINOIS STREET SAN FRANCISCO, CA 94158

FibroGen, Inc. is a research-based pharmaceutical company focused on the discovery, development and commercialization of novel therapeutic agents to treat serious unmet medical needs. The Company has a global approach to the development and commercialization of its products.

Data as of 2021-05-08 11:38:10 -0400
Market Cap1.863 Billion Shares Outstanding92.069 Million Avg 30-day Volume1.619 Million
P/E Ratio-9.83962 Dividend Yield EPS-2.11
Price/Sales10.56 Debt to Equity1.96 EBITDA-180.404 Million
Price to Book Value4.41 Forward PE-13.83 Enterprise Value1.214 Billion
Total Cash686.537 Million Current Debt163.187 Million Gross Profit167.45 Million
BETA1.25452 52-week High/Low57.21 / 18.12 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from FGEN instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 211 206 2.43% 55 (3.3%) 63 (3.92%) -12.7%
13F shares: 71.92 Million 68.088 Million 5.63% 12.386 Million 12.386 Million -0.0%
% Ownership 79.0235 74.8135 5.63% 13.6088 13.6095 -0.01%
New Positions: 29 37 -21.62% 8 9 -11.11%
Increased Positions 70 67 4.48% 10 15 -33.33%
Closed Positions 25 22 13.64% 16 13 23.08%
Reduced Positions 73 72 1.39% 22 27 -18.52%
Total Calls 1.254 Million 417.004 Thousand 200.69% 770.835 Thousand 248.231 Thousand 210.53%
Total Puts 851.665 Thousand 572.107 Thousand 48.86% 393.971 Thousand 320.138 Thousand 23.06%
PUT/CALL Ratio 0.68 1.37 -50.36% 0.51 1.29 -60.47%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KEARNS THOMAS F JR

  • Director
258,164 2021-03-11 2

COTRONEO PAT SVP, FINANCE AND CFO

  • Officer
282,187 2021-03-08 10

KOUCHAKJI ELIAS SVP, CLINICAL DEV, DRUG SAFETY

  • Officer
147,346 2021-03-08 6

CHUNG CHRISTINE SVP, CHINA OPERATIONS

  • Officer
166,597 2021-03-08 5

CONTERNO ENRIQUE A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
329,073 2021-02-24 3

WETTIG THANE CHIEF COMMERCIAL OFFICER

  • Officer
79,250 2021-02-24 4

KURKIJARVI KALEVI

  • Director
33,100 2021-02-17 5

SCHOENECK JAMES A

  • Director
80,822 2021-01-04 3

YU K PEONY CHIEF MEDICAL OFFICER

  • Officer
192,292 2020-12-16 7

EISNER MARK INCOMING CHIEF MEDICAL OFFICER

  • Officer
35,000 2020-12-01 2

CRAVATT BENJAMIN

  • Director
0 2020-08-05 2

BRENNAN AOIFE

  • Director
0 2020-08-05 2

ROSENKRANZ ROBERTO PEDRO

  • Director
96,100 2020-06-09 2

RIGGS RORY B

  • Director
996,763 2020-06-04 1

HENDERSON JEFFREY WILLIAM

  • Director
13,100 2020-06-04 1

EDWARDS JEFFREY L

  • Director
13,100 2020-06-04 1

LEMA GERALD

  • Director
16,600 2020-06-04 1

HO MAYKIN

  • Director
11,255 2020-06-04 1

BLAUG SUZANNE

  • Director
9,348 2020-06-04 1

NEFF THOMAS B CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
2,451,796 2019-08-21 0

TAMURA TOSHINARI

  • Director
56,400 2019-06-05 0

ROUTTI JORMA

  • Director
161,540 2019-03-26 0

STERN JULIAN N

  • Director
0 2016-06-08 0

VALONE FRANK H MD CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2016-04-01 0

MADERO MIGUEL

  • Director
425,246 2015-12-08 0

ASTELLAS PHARMA INC.

  • FORMER 10% HOLDER
No longer subject to file 2014-11-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FIBROGEN INC FGEN 2021-05-14 22:15:03 UTC -0.2036 0.2536 1400000
FIBROGEN INC FGEN 2021-05-14 21:45:03 UTC -0.2036 0.2536 1400000
FIBROGEN INC FGEN 2021-05-14 21:15:03 UTC -0.2036 0.2536 1400000
FIBROGEN INC FGEN 2021-05-14 20:45:03 UTC -0.2044 0.2544 1400000
FIBROGEN INC FGEN 2021-05-14 20:15:04 UTC -0.2044 0.2544 1400000
FIBROGEN INC FGEN 2021-05-14 19:45:02 UTC -0.2044 0.2544 1400000
FIBROGEN INC FGEN 2021-05-14 19:15:03 UTC -0.2044 0.2544 1400000
FIBROGEN INC FGEN 2021-05-14 18:45:03 UTC -0.2 0.25 1400000
FIBROGEN INC FGEN 2021-05-14 18:15:03 UTC -0.2 0.25 1400000
FIBROGEN INC FGEN 2021-05-14 17:45:03 UTC -0.2 0.25 1400000
FIBROGEN INC FGEN 2021-05-14 17:15:03 UTC -0.2 0.25 1400000
FIBROGEN INC FGEN 2021-05-14 16:45:03 UTC -0.2221 0.2721 1400000
FIBROGEN INC FGEN 2021-05-14 16:15:03 UTC -0.2221 0.2721 1400000
FIBROGEN INC FGEN 2021-05-14 15:45:03 UTC -0.2221 0.2721 1400000
FIBROGEN INC FGEN 2021-05-14 15:15:02 UTC -0.2221 0.2721 1400000
FIBROGEN INC FGEN 2021-05-14 14:45:04 UTC -0.2097 0.2597 1400000
FIBROGEN INC FGEN 2021-05-14 14:15:03 UTC -0.2097 0.2597 1400000
FIBROGEN INC FGEN 2021-05-14 13:45:03 UTC -0.2097 0.2597 1400000
FIBROGEN INC FGEN 2021-05-14 13:15:03 UTC -0.2097 0.2597 1400000
FIBROGEN INC FGEN 2021-05-14 12:45:03 UTC -0.2097 0.2597 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund FGEN -73.0 shares, $-3001.76 2020-09-30 N-PORT
Advisors Series Trust- Pzena Long/Short Value Fund FGEN -3425.0 shares, $-114532.0 2020-05-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund FGEN -919.0 shares, $-34085.71 2020-12-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund FGEN -190.0 shares, $-6602.5 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund FGEN -57.0 shares, $-1980.75 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund FGEN -76.0 shares, $-3125.12 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund FGEN -172.0 shares, $-5977.0 2020-03-31 N-PORT
Alger Funds II- Alger Dynamic Opportunities Fund FGEN -23565.0 shares, $-1135361.7 2021-01-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Anti-Beta Fund FGEN -8816.0 shares, $-306003.36 2021-03-31 N-PORT

Elevate your investments